Cohen Lawrence B Novartis Ag Transaction History

Cohen Lawrence B

$2.06 Billion
Q4 2023

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$94.73 - $105.13 $31,260 - $34,692	330 Added 1.32%	25,344 $2.58 Million
Q2 2023 Jul 27, 2023	SELL	$92.52 - $104.91 $10,917 - $12,379	-118 Reduced 0.47%	25,014 $2.52 Million
Q1 2023 May 11, 2023	BUY	$80.03 - $92.81 $87,472 - $101,441	1,093 Added 4.55%	25,132 $2.31 Million
Q4 2022 Feb 08, 2023	BUY	$75.55 - $92.52 $28,709 - $35,157	380 Added 1.61%	24,039 $2.18 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $151,010 - $176,614	-2,024 Reduced 7.88%	23,659 $1.8 Million
Q3 2022 Nov 09, 2022	BUY	$74.61 - $87.26 $87,069 - $101,832	1,167 Added 4.76%	25,683 $2.25 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $93,966 - $109,406	-1,167 Reduced 4.54%	24,516 $2.07 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $11,535 - $13,049	-144 Reduced 0.56%	25,683 $2.25 Million
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $238,701 - $263,949	-2,995 Reduced 10.39%	25,827 $2.26 Million
Q3 2021 Oct 26, 2021	SELL	$81.78 - $95.14 $119,317 - $138,809	-1,459 Reduced 4.82%	28,822 $2.36 Million
Q2 2021 Jul 14, 2021	BUY	$85.24 - $94.15 $19,775 - $21,842	232 Added 0.77%	30,281 $2.76 Million
Q1 2021 Apr 26, 2021	SELL	$83.5 - $98.47 $26,720 - $31,510	-320 Reduced 1.05%	30,049 $2.57 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $18,892 - $22,852	242 Added 0.8%	30,369 $2.87 Million
Q3 2020 Nov 03, 2020	BUY	$82.14 - $91.0 $5,092 - $5,642	62 Added 0.21%	30,127 $2.62 Million
Q2 2020 Jul 23, 2020	SELL	$80.93 - $91.1 $7,364 - $8,290	-91 Reduced 0.3%	30,065 $2.63 Million
Q1 2020 Apr 22, 2020	BUY	$70.67 - $99.01 $74,203 - $103,960	1,050 Added 3.61%	30,156 $2.49 Million
Q4 2019 Jan 27, 2020	BUY	$84.35 - $95.37 $37,788 - $42,725	448 Added 1.56%	29,106 $2.76 Million
Q3 2019 Nov 04, 2019	SELL	$85.54 - $94.26 $57,568 - $63,436	-673 Reduced 2.29%	28,658 $2.49 Million
Q2 2019 Aug 01, 2019	SELL	$75.4 - $92.8 $37,323 - $45,936	-495 Reduced 1.66%	29,331 $2.68 Million
Q1 2019 Apr 17, 2019	SELL	$75.32 - $86.15 $3,314 - $3,790	-44 Reduced 0.15%	29,826 $2.87 Million
Q4 2018 Jan 14, 2019	BUY	$73.66 - $82.02 $23,939 - $26,656	325 Added 1.1%	29,870 $2.56 Million
Q3 2018 Oct 23, 2018	BUY	$66.94 - $77.43 $33,470 - $38,715	500 Added 1.72%	29,545 $2.55 Million
Q2 2018 Jul 26, 2018	SELL	$64.91 - $73.36 $116,838 - $132,048	-1,800 Reduced 5.84%	29,045 $2.19 Million
Q1 2018 Apr 19, 2018	BUY	$70.39 - $84.15 $105,936 - $126,645	1,505 Added 5.13%	30,845 $2.49 Million
Q4 2017 Feb 06, 2018	BUY	$72.33 - $77.64 $40,432 - $43,400	559 Added 1.94%	29,340 $2.46 Million
Q3 2017 Nov 03, 2017	BUY	$74.14 - $77.27 $2.13 Million - $2.22 Million	28,781	28,781 $2.47 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Lawrence B, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Lawrence B with notifications on news.

Account